Vaislic, MFM book chapter, page proofs, 12.5.16

Introduction Outcomes are now available out to 4 years for the prospective nonrandomized STRATO trial. Th is 10-center French study was undertaken between April 2010 and February 2011 in order to assess the effi cacy, safety, and performance of the

Three-Year Outcomes With the Multilayer Flow Modulator for Repair of Thoracoabdominal Aneurysms: A Follow-up Report From the STRATO Trial Journal of endovascular therapy

Vaislic C. and al Abstract Purpose: To evaluate midterm outcomes of endovascular repair of types II and III thoracoabdominal aortic aneurysms (TAAA) using the Multilayer Flow Modulator (MFM) in patients unsuitable for open surgery or fenestrated stent-grafts. Methods: In the

Feasibility of sutureless valve implantation in reoperation for degenerated 19 mm aortic valvular bioprostheses

Vola M, Campisi S, Anselmi A, Vaislic C, Fuzellier JF. Abstract BACKGROUND AND AIM OF THE STUDY: Transcatheter aortic valve implantation (TAVI) is a promising option to treat degenerated aortic valve bioprostheses, and may involve Valve-in-Valve (ViV) procedures. Unfortunately, the

1 2 3 6